THERAPEUTIC PROTEINS INT LLC has a total of 51 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, chemical engineering and measurement are NIAZI SARFARAZ, CMC BIOLOGICS AS and UNIVERCELLS S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 15 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Canada | 8 | |
#4 | China | 7 | |
#5 | Australia | 6 | |
#6 | United States | 4 | |
#7 | Hong Kong | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Chemical engineering | |
#3 | Measurement | |
#4 | Pharmaceuticals | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microbiology | |
#2 | Peptides | |
#3 | Separation | |
#4 | Analysing materials | |
#5 | Chemical or physical processes | |
#6 | Mixing | |
#7 | Measuring microorganism processes | |
#8 | Storage of greenhouse gases | |
#9 | Fermentation | |
#10 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Niazi Sarfaraz | 30 |
#2 | Niazi Sarfaraz K | 17 |
#3 | Wilton Rosemarie | 4 |
Publication | Filing date | Title |
---|---|---|
EP3030263A1 | Comparing the structures of two biomolecules | |
US2014356968A1 | Methods for comparing a structure of a first biomolecule and a second biomolecule | |
WO2013126560A2 | Non-blocking filtration system | |
AU2012366290A1 | Stabilization of the anti-CD20 antibody Rituximab |